Garland J. Scottinsider trades
In SEC Form 4 filings, Garland J. Scott is listed as Director of Enliven Therapeutics, Inc. (ELVN). In the last 90 days, Garland J. Scott sold $606.7K of Enliven Therapeutics, Inc. (ELVN) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ELVNEnliven Therapeutics, Inc. | Director | 3 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-05
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ELVNEnliven Therapeutics, Inc. | Oct 1 | Oct 5 | M | 13,000 | $15.47 | $201,110 | 13,000 | No | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Oct 1 | Oct 5 | S | 13,000 | $46.67 | Sale −$606,719 | not reported | No | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Oct 1 | Oct 5 | M · derivative | 13,000 | $15.47 | $201,110 | 46,372 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.